303 related articles for article (PubMed ID: 15085463)
1. Low-molecular-weight heparin in thrombosis and cancer.
Mousa SA
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():25-30. PubMed ID: 15085463
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotics in thrombosis and cancer.
Mousa SA
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):283-91. PubMed ID: 15030287
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulants in thrombosis and cancer: the missing link.
Mousa SA
Semin Thromb Hemost; 2002 Feb; 28(1):45-52. PubMed ID: 11885025
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulants in thrombosis and cancer: the missing link.
Mousa SA
Expert Rev Anticancer Ther; 2002 Apr; 2(2):227-33. PubMed ID: 12113244
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotics in thrombosis and cancer.
Mousa SA
Hamostaseologie; 2005 Nov; 25(4):380-6. PubMed ID: 16395488
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin in oncology.
Zacharski LR; Loynes JT
Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparins and angiogenesis.
Norrby K
APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence.
Mousa SA; Petersen LJ
Thromb Haemost; 2009 Aug; 102(2):258-67. PubMed ID: 19652876
[TBL] [Abstract][Full Text] [Related]
9. Anti-thrombotics in thrombosis and cancer.
Mousa SA
Future Oncol; 2005 Jun; 1(3):395-403. PubMed ID: 16556013
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparins in thrombosis and cancer: emerging links.
Mousa SA
Cardiovasc Drug Rev; 2004; 22(2):121-34. PubMed ID: 15179449
[TBL] [Abstract][Full Text] [Related]
13. Cancer and thromboembolism: from biology to clinics.
Castelli R; Porro F
Minerva Med; 2006 Apr; 97(2):175-89. PubMed ID: 16760856
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
15. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
Kher A; Bauersachs R; Nielsen JD
Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
17. The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer.
Lee AY
Thromb Res; 2007; 120 Suppl 2():S121-7. PubMed ID: 18023705
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
Pruemer J
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
[TBL] [Abstract][Full Text] [Related]
19. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
20. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Timely Top Med Cardiovasc Dis; 2006 Aug; 10():E19. PubMed ID: 17066136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]